Streetbeat News

Revenues

VTLE

Analysts have varied opinions on Vital Energy (NYSE:VTLE), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has decreased by 14.88% to $51.5. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Despite a notable revenue growth rate of 42.17%, Vital Energy faces challenges with profitability and returns.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 4:00 pm

CAT

Caterpillar (NYSE:CAT) has been analyzed by six analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has increased to $358.33. Analysts have adjusted their ratings and price targets based on market conditions and company performance. Despite a recent revenue decline, Caterpillar maintains strong net margins and return on equity, though it carries a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 4:00 pm

ZTS

Zoetis (NYSE:ZTS) has significantly outperformed the market over the past decade, with an annualized return of 18.1%. A $1000 investment in Zoetis 10 years ago would now be worth $5,144.18, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 4:00 pm

CDW

CDW Corporation (NASDAQ:CDW) has significantly outperformed the market over the past decade, delivering an average annual return of 22.35%. A $100 investment in CDW 10 years ago would now be worth $741.41, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 4:00 pm

NAVI

Analysts have mixed ratings for Navient (NASDAQ:NAVI), with recent sentiment showing a slight negative shift. The average 12-month price target is $14.6, with a high of $17.00 and a low of $10.00. Navient faces financial challenges, including a 19.54% revenue decline and high debt-to-equity ratio, but maintains a strong net margin.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 4:00 pm

FCX

Freeport-McMoRan has delayed copper production at its $3.7 billion Manyar smelter in Indonesia to November due to water and steam leakage issues. This delay also affects the delivery of samples to potential clients.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:50 pm

CCL

Carnival CEO Josh Weinstein discussed the company's growth strategy on CNBC, focusing on future plans and market positioning.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:45 pm

LLY

NVO

RHHBY

Roche Holdings AG is accelerating the development of its obesity drug CT-388, aiming for over $3 billion in sales. The company is also cutting drug development costs and time, with plans to launch 20 transformative medicines by 2030. Roche is expanding its portfolio with a $850 million acquisition from Regor Pharmaceuticals.

Portfolio Pulse from Vandana Singh

September 30, 2024 | 3:39 pm

NOW

ServiceNow (NYSE:NOW) has significantly outperformed the market over the past decade, with an annualized return of 31.32%. A $100 investment in ServiceNow 10 years ago would now be worth $1,457.36, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 3:30 pm

LRCX

Lam Research (NASDAQ:LRCX) has significantly outperformed the market over the past 20 years, with an average annual return of 19.68%. A $100 investment in LRCX 20 years ago would now be worth $3,556.23. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 3:30 pm